POZEN announced positive top-line results from two randomized, double-blind, multi-center, pivotal Phase 3 clinical trials of PA32540, a novel, coordinated-delivery tablet of immediate-release omeprazole and delayed release aspirin. Detailed …
Shouguang Fukang Pharmaceutical Co., Ltd.
Trimethoprim|TMP|Omeprazole|Sulfamethoxazole|SMZ|Metformin HCl|Bromide compounds